Truist Financial Corp trimmed its position in Option Care Health, Inc. (NASDAQ:OPCH – Free Report) by 18.2% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 8,271 shares of the company’s stock after selling 1,839 shares during the period. Truist Financial Corp’s holdings in Option Care Health were worth $279,000 at the end of the most recent quarter.
A number of other institutional investors have also added to or reduced their stakes in the company. Cambridge Investment Research Advisors Inc. increased its holdings in shares of Option Care Health by 9.7% during the third quarter. Cambridge Investment Research Advisors Inc. now owns 10,855 shares of the company’s stock valued at $351,000 after acquiring an additional 957 shares in the last quarter. Raymond James & Associates grew its position in Option Care Health by 12.7% in the 3rd quarter. Raymond James & Associates now owns 16,633 shares of the company’s stock valued at $538,000 after purchasing an additional 1,877 shares during the period. Fifth Third Bancorp increased its stake in Option Care Health by 219.6% during the 3rd quarter. Fifth Third Bancorp now owns 2,723 shares of the company’s stock valued at $88,000 after purchasing an additional 1,871 shares in the last quarter. Principal Financial Group Inc. raised its holdings in Option Care Health by 39.8% during the third quarter. Principal Financial Group Inc. now owns 905,784 shares of the company’s stock worth $29,302,000 after buying an additional 257,852 shares during the last quarter. Finally, California Public Employees Retirement System lifted its stake in shares of Option Care Health by 10.1% in the third quarter. California Public Employees Retirement System now owns 317,450 shares of the company’s stock valued at $10,270,000 after buying an additional 29,045 shares in the last quarter. 98.05% of the stock is owned by institutional investors and hedge funds.
Option Care Health Price Performance
OPCH opened at $29.06 on Tuesday. Option Care Health, Inc. has a 1 year low of $26.17 and a 1 year high of $35.74. The company has a debt-to-equity ratio of 0.74, a current ratio of 1.77 and a quick ratio of 1.39. The company has a market capitalization of $5.05 billion, a price-to-earnings ratio of 19.12, a P/E/G ratio of 1.45 and a beta of 1.26. The firm’s fifty day moving average price is $31.13 and its two-hundred day moving average price is $31.44.
Option Care Health (NASDAQ:OPCH – Get Free Report) last released its quarterly earnings results on Tuesday, April 23rd. The company reported $0.26 earnings per share for the quarter, topping the consensus estimate of $0.22 by $0.04. The business had revenue of $1.15 billion for the quarter, compared to analysts’ expectations of $1.10 billion. Option Care Health had a net margin of 6.15% and a return on equity of 18.92%. The firm’s revenue for the quarter was up 12.8% compared to the same quarter last year. During the same period in the previous year, the company earned $0.21 earnings per share. As a group, analysts anticipate that Option Care Health, Inc. will post 1.19 earnings per share for the current fiscal year.
Analysts Set New Price Targets
A number of equities research analysts recently weighed in on OPCH shares. Jefferies Financial Group upped their target price on shares of Option Care Health from $36.00 to $38.00 and gave the stock a “buy” rating in a report on Monday, March 4th. Barrington Research reissued an “outperform” rating and issued a $38.00 price objective on shares of Option Care Health in a research note on Wednesday, April 24th.
Check Out Our Latest Stock Analysis on Option Care Health
Insider Activity at Option Care Health
In other Option Care Health news, Director Harry M. Jansen Kraemer, Jr. acquired 35,000 shares of the business’s stock in a transaction on Monday, February 26th. The shares were acquired at an average price of $31.55 per share, with a total value of $1,104,250.00. Following the completion of the transaction, the director now owns 269,528 shares in the company, valued at $8,503,608.40. The acquisition was disclosed in a legal filing with the SEC, which is available at the SEC website. 0.64% of the stock is currently owned by company insiders.
About Option Care Health
Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.
Further Reading
Want to see what other hedge funds are holding OPCH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Option Care Health, Inc. (NASDAQ:OPCH – Free Report).
Receive News & Ratings for Option Care Health Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Option Care Health and related companies with MarketBeat.com’s FREE daily email newsletter.
Source: defenseworld.net
